The 2026 NICU Leadership Forum, hosted by Synova Associates, brought together neonatal leaders from across the country to explore innovation, leadership, and the future of care inside one of the most sensitive clinical environments—the NICU. Held in Florida from April 12–14, the event focused on strengthening outcomes through smarter systems, safer workflows, and stronger collaboration among care teams.
For Seal Shield, Synova 2026 was an opportunity to do more than showcase products—it was a chance to demonstrate how infection prevention technology is evolving to meet the unique challenges of neonatal care.
A Hands-On Look at Infection Prevention in the NICU
Throughout the conference, attendees experienced Seal Shield’s full suite of UV-C sanitization solutions, purpose-built for healthcare—and increasingly critical in NICU environments where shared devices are constant touchpoints.
From mobile phones and tablets to scanners and clinical tools, NICU teams are managing an expanding ecosystem of shared technology. These devices, while essential to care delivery, can also act as vectors for cross-contamination if not consistently sanitized.
Seal Shield’s solutions—such as CleanSlate UV Vital, ElectroClave and now including the Vioguard Cubby+ — address this challenge by delivering:
- Rapid, automated UV-C sanitization cycles
- Consistent, repeatable sanitization without chemicals
- Workflow-friendly integration at key NICU touchpoints especially at Nurses and Handwashing Stations
This hands-on experience resonated strongly with nurse leaders seeking scalable, easy-to-adopt infection control strategies that align with evolving clinical expectations. With over 75 NICUs already deploying these types of solutions across North America, the adoption of UV-C sanitization is rapidly becoming a new standard in neonatal care.
Proven UV-C Efficacy Against Dangerous Pathogens
A major highlight at Synova 2026 was the demonstrated efficacy of Seal Shield’s UV-C technology against some of the most dangerous pathogens found in healthcare environments. Seal Shield’s UV systems are engineered to inactivate up to 99.999% of bacteria and viruses—including high-risk organisms such as MRSA and C. difficile.
This level of efficacy, achieved in rapid cycles (as fast as ~20 seconds depending on the device), provides NICU teams with a high-confidence, high-compliance solution that minimizes reliance on manual cleaning processes.
In an environment where patients are among the most vulnerable, this kind of consistent, measurable protection is not just beneficial—it’s essential.
Designed for the NICU: Seal Silk Pro Keyboard
Beyond UV sanitization, Seal Shield also highlighted its Seal Silk Pro keyboard, specifically designed for NICU and clinical environments.
Attendees were able to experience firsthand how the keyboard supports infection prevention and usability:
- Fully sealed, washable design compatible with hospital-grade disinfectants
- Smooth, non-porous surface to eliminate bacteria harborage points
- Quiet, tactile typing experience ideal for sensitive NICU settings
- Durability built for continuous cleaning protocols
In the NICU, where equipment must balance hygiene with caregiver usability, the Seal Silk Pro stood out as a solution that meets both demands without compromise.
Supporting Safer Workflows for the Most Vulnerable Patients
The conversations at Synova 2026 made one thing clear: infection prevention in the NICU is no longer limited to hand hygiene and surface cleaning—it now includes every shared device in the care environment.
Seal Shield’s presence at the conference reinforced a broader shift happening across neonatal care:
- From reactive cleaning → proactive, automated sanitization
- From inconsistent processes → standardized, trackable workflows
- From isolated solutions → integrated infection control ecosystems
Looking Ahead
As NICU leaders continue to prioritize patient safety, staff efficiency, and regulatory alignment, technologies like UV-C sanitization and purpose-built medical peripherals will play an increasingly central role.
Seal Shield’s showcase at Synova 2026 wasn’t just about innovation—it was about practical, proven solutions that help NICUs reduce risk, improve compliance, and ultimately protect the smallest and most vulnerable patients.
Because in the NICU, every touchpoint matters.
